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Case Report 
HW is 22-year-old G3P1 ill-appearing 
Haitian female.  She presents to a local 
mission center holding her gravid 
abdomen and complaining of “doulé 
akouman”, or sharp labor pains.  The 
mission offers little more than an exam 
table and several shelves of basic 
medications.  Several female community 
health agents (CHA) staff the “clinic” 
once a week to do blood pressure 
checks and bridge the care between 
visiting teams of American physicians. 
CHAs are community laypersons trained 
to do public health education and check 
vitals. Fortunately, today an American 
medical student and resident physician 
are also present.  Suspicious of the 
pains and swollen appearance of the 
woman, they take a blood pressure and 
dip her urine.  This reveals a blood 
pressure of 200/110 and 4+ proteinuria. 
On exam, a transverse incision is 
evident which elicits a history of aC-
section. She has an unknown 
gestational age, zero prenatal care, and 
is currently contracting. The nearest 
hospital is a 40-minute “taptap” ride 
away, which she cannot afford.  
Introduction 
Preeclampsia is a complex multi-
pathway disease process diagnosed by 
hypertension with two readings of 
systolic blood pressure ≥ 140 mmHg 
and/or diastolic BP ≥ 90 mmHg, 
separated by a 4-6 hour period, and 
proteinuria with a urine dipstick of ≥ 1+ 
or ≥ 300 mg per 24 hours, after 20 
weeks’ gestation in a previously 
normotensive patient. Eclampsia, new 
onset of grand mal seizures during or 
after pregnancy without any other 
identifiable cause is one risk that can 
follow the diagnosis of pre-eclampsia. 
The overall risk of seizure is 1%, and is 
preventable with use of Magnesium 
Sulfate in women with severe 
preeclampsia, such as this patient.  
Severe preeclampsia is defined as a 
systolic BP ≥ 160 mmHg or diastolic BP 
≥ 110 mmHg, measured twice at least 6 
hours apart or evidence of other end 
organ damage, including presence of 
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renal failure, liver dysfunction, central 
nervous system disturbance, pulmonary 
edema, or right upper quadrant pain.   
Ninety-nine percent of pregnancy 
related deaths occur in middle and low-
income countries (LMIC). Of these 
deaths, the World Health Organization 
(WHO) ranks pre-eclampsia and 
eclampsia as the second leading direct 
cause of maternal morbidity and 
mortality, behind only postpartum 
hemorrhage.  A woman born in a 
developing country has a seven times 
greater risk of developing pre-eclampsia 
and a three times greater risk of 
progressing to eclampsia.  Within the 
realm of eclampsia, she has roughly a 
fourteen times greater risk of death.  
Additionally, infant mortality in women 
with preeclampsia is 3 times higher in 
LMIC than in high-income countries.   
While this journal’s special issue 
addresses advancements in our 
scientific understanding of pre-
eclampsia, this paper seeks to review 
what we know about the basics of 
detection and management to 
encourage thoughtful applications in 
improving the global burden of pre-
eclampsia and eclampsia in low 
resources settings.   
Access Limitations 
The patient is known to live 25 miles 
away, but to cover this mountainous 
distance requires hours of travel on 
either donkey or motorcycle on 
unpaved, narrow mountain passages. 
She came to this mission because she 
knows sometimes the “blan” (White) 
doctors are here.  The public hospital is 
another 30 minutes away, but she is 
hesitant to go because she knows she 
will have to bribe the nurses to be seen 
by a physician, and the cost of a c-
section is more than she makes in a 
month.  
The majority of maternal morbidity and 
mortality is due to limited access of 
prenatal care and obstetrical 
intervention. In high-income countries, 
98% of women report having at least 
one prenatal visit, compared to only 
68% in LMIC.   A further dichotomy 
exists in rural vs urban settings 
worldwide. The WHO sets a standard 
goal of at least four prenatal visits.  Only 
61% of women in urban areas and 39% 
of women in rural areas meet this goal. 
Common barriers to care include 
traveling long distances, fees, childcare, 
financial autonomy, and a shortage of 
providers, especially female. These 
same barriers prevent women from 
delivering at a health facility. A survey in 
41 LMIC showed that nearly a quarter of 
women said they did not go to the health 
facility for delivery because a male 
provider staffed it.   Even among the 
68% of women obtaining a prenatal visit, 
further barriers exist in diagnostics. One 
study found that 15-30% of women 
obtaining prenatal care never had their 
blood pressure checked.  The WHO 
recommends urine dipsticks for 
proteinuria only in nulliparous women or 
those with a history of pre-eclampsia.  
Limitations in proper point of care 
testing include cost and availability of 
dipsticks, as well as proper training and 
equipment to accurately measure blood 
pressure.  
Diagnostics 
HW noticed swelling in her hands and 
feet several weeks ago, but a 
community elder told her it was normal 
and gave her an herbal tea to help the 
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symptoms.  She never saw a health 
care provider for prenatal care, and 
planned to deliver the child at home with 
a community midwife -- a locally 
appointed woman with no formal 
training. 
Diagnostic limitations mean that a 
careful physical exam and early 
recognition of physical findings is vital in 
these situations.  Educating women and 
midlevel community providers to 
recognize acute onset edema may 
reduce complications and delays. One 
interesting “mom-edema-meter” 
prototype has been proposed in the 
form of a wristband that is comfortable 
yet snug enough to quantify expansion 
caused by edema.  When specified 
measurements are reached, the woman 
has been told to seek further medical 
care.   
Another effective strategy in diagnosis is 
utilizing community health workers as 
liaisons between rural communities and 
nearby hospitals.  Community health 
workers are lay members of the 
community who work within the local 
health system with the advantage of 
working more intimately with community 
members and sharing cultural traditions. 
If they can be trained and equipped to 
obtain basic pressure and protein 
studies at home visits, they can work 
within the local health system and 
prearrange necessary triage and 
transport.  
Modern communication technologies 
are a promising tool for assisting the 
community health worker.  People in 
LMIC have increasing access to cellular 
technologies, offering a much wider 
reach for communication of public health 
messages. These telecommunication 
strategies range from simple as generic 
text reminders to complex patient 
sensors to monitor vitals at home and 
report them to a central hub which can 
be overseen my medical professionals.  
Interventions 
The patient is moaning in pain, so the 
American doctors work fast. Luckily, 
there is one vial of magnesium sulfate 
on the dusty shelf along with a liter of 
intravenous fluids. Before intravenous 
access can be achieved, HW begins to 
seize. While the family medicine 
resident stabilizes the patient, the 
medical student runs down the road 
looking for the nearest “tap-tap” to 
provide public transportation to the 
public hospital. Ambulances in this town 
are only called to haul away dead 
bodies.  
Even when pre-eclampsia is diagnosed, 
further hurdles exist in obtaining the 
necessary emergent interventions. If 
community health workers serve as the 
first point of contact for many women, 
the ideal antihypertensive treatment 
would be an oral medication with one 
time dosing. Insufficient evidence exists 
to support use of oral medication in 
severe hypertension of pregnancy.   
Even notoriously cheap and effective 
magnesium sulfate is underutilized due 
to limited supply, limited provider 
knowledge and training, fear of 
administration due to limited monitoring, 
and lack of national protocols.  
Evidence-based information 
dissemination is needed.   
Prevention 
Without adequate antenatal care and 
imaging, effective prevention strategies 
Proceedings in Obstetrics and Gynecology, 2013;3(1):1 
Pre-eclampsia and global challenges 4 
 
are of great value. Aspirin is associated 
with a 10-19% reduction in pre-
eclampsia, and a 10-16% decrease in 
perinatal morbidity and mortality in 
women determined to be at “moderate 
to high risk” by their medical, obstetric, 
and family histories as well as 
ultrasound findings.    Identifying these 
moderate-high risk groups may be 
difficult, as most women have at least 
one risk factor (both multiparity and 
nulliparity are listed as risks). Even this 
small reduction in incidence has the 
potential to make a great impact on 
women who may otherwise have no 
monitoring.  The low cost and safety 
profile of the drug are encouraging for 
application in routine OB care in low 
resource settings. There is some 
evidence to suggest a preventative role 
for calcium, especially in nutrient 
deficient women with hypocalcaemia at 
baseline.  Randomized controlled trials 
are underway, and several initiatives 
have been proposed to refine the large, 
chalky tablets into a lower-cost, smaller, 
and more appetizing version. In Haiti, 
over-the-counter “Tums” are more 
readily available and comfortably utilized 
in both market and clinical settings. 
These small preventative measures 
have the potential to make a large 
impact on patients like the one featured 
in this article.   
Conclusions 
HW was carried unwillingly into the back 
of a truck, where an IV was started to 
administer fluids and magnesium 
sulfate. 40 minutes of bumpy driving 
with the sick mother finally paid off when 
they reached the Cuban physician 
staffing the public clinic.  Fortunately, 
her blood pressure was controlled with 
IV labetolol; she was continued on 
magnesium and had no further seizures. 
She vaginally delivered a small baby 
boy, and was able to follow up with the 
CHAs for blood pressure checks each 
week.  
The need for prevention, detection, and 
treatment of pre-eclampsia is immense, 
especially in low income countries like 
Haiti. While Iowa City boasts 52 
physicians per 10,000 people, in Haiti 
(just a several hour flight away) the ratio 
is 10 physicians per 10,000 people.  
Haitian obstetrical practices and 
maternal and infant health are 
particularly concerning.  During 
childbirth, only 1/4 Haitian women will 
have a “skilled” attendant at her side, 
and three of every 1000 will die during 
the process.  We have developed 
amazing technologies in the field of 
women’s health, but if only a few women 
have access to them, are we really 
doing a service to women of the world?  
Few interventions have a greater impact 
than basic prenatal care:  a physical 
exam in educated hands, cheap 
medications, and diagnostics as simple 
as a sphygmomanometer and urine 
dipsticks. As women’s health 
professionals, we must be more pro-
active in sharing our wealth of 
educational opportunities and 
advocating for the underserved women 
of the world.   
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underserved Haitians. CHI visits the 
same Haitian communities every three 
months with a full medical team, and 
pays monthly stipends to five local 
women to work as Community Health 
Agents to deliver basic health education 
and services. The urgency and danger 
of the case profiled in this article hit 
close to home for Rachel and other CHI 
providers, sparking a drive to push for 
more aggressive prenatal care 
measures. Rachel and CHI colleagues 
have worked closely with these women 
to perform and document at least four 
routine prenatal home visits equipped 
with urine dipsticks, blood pressure 
cuffs, and knowledge.  CHI is working to 
obtain evidence to support these 
measures, and has recently launched a 
new electronic medical records system 
for use at quarterly clinics. A long-term 
goal is to incorporate data from health 
worker home visits into the system for 
improved patient monitoring.  
CHI offers opportunities for health 
professionals and students to share 
their talents through clinical service and 
community education. All local 
community members are welcome to be 
involved in the Community Health 
Initiative, lead locally by UI physicians 
Dr. Chris Buresh, Dr. Ginny Ryan, and a 
supporting group of students. Please 
contact CHI or Rachel if you are 
interested in getting more involved!  
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